{
  "personality": null,
  "timestamp": "2025-11-14T04:42:49.778516",
  "category": "Health",
  "news_summary": "Advances in targeted cancer therapies, innovative xenotransplantation research, breakthroughs in drug-delivering nanorobots, and a strong focus on health protection amid climate change highlight today's promising developments in medical science.",
  "news_summary_fr": "Les progrès des thérapies ciblées contre le cancer, la recherche innovante en matière de xénotransplantation, les percées dans le domaine des nanorobots vecteurs de médicaments et l'accent mis sur la protection de la santé dans le contexte du changement climatique sont autant d'éléments qui illustrent les développements prometteurs de la science médicale d'aujourd'hui.",
  "news_summary_es": "Los avances en terapias selectivas contra el cáncer, la investigación innovadora en xenotrasplantes, los avances en nanorobots que administran fármacos y la gran atención prestada a la protección de la salud frente al cambio climático ponen de relieve los prometedores avances actuales de la ciencia médica.",
  "articles": [
    {
      "title": "Smart drug strikes a hidden RNA weak point in cancer cells",
      "summary": "Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it. Tests showed that removing this RNA slows cancer growth. The approach could lead to new treatments that attack cancer at its most fundamental level.",
      "content": "Researchers have designed a new class of drug molecule capable of specifically destroying TERRA, an RNA molecule that some cancer cells rely on to survive. Using a technique known as \"RIBOTAC,\" the compound is able to locate TERRA inside the cell and break it apart while avoiding healthy RNA. The work suggests a possible path toward future cancer therapies that focus on the genetic drivers of disease rather than its outward effects.\n\nA team from the Hebrew University of Jerusalem has created a drug-like molecule that can locate and eliminate an RNA segment tied to cancer development. The study, published in Advanced Sciences, was conducted by Dr. Raphael I. Benhamou, Elias Khaskia, and Dipak Dahatonde of the university's Faculty of Medicine. Their research centers on TERRA, an RNA molecule that helps maintain the ends of chromosomes -- the regions of DNA that support cell stability and overall health.\n\nWhen TERRA functions improperly, it can disrupt normal cell aging and division. In several cancers, including certain tumors of the brain and bone, cancer cells exploit TERRA to continue growing and dividing.\n\n\"We've created a tool that acts like a guided missile for bad RNA,\" said Dr. Benhamou. \"It can find TERRA inside cancer cells and make it disappear -- without harming healthy parts of the cell.\"\n\nHow the RIBOTAC Molecule Works\n\nThe researchers built a small molecule using RIBOTAC, short for Ribonuclease-Targeting Chimera. This molecule identifies a distinctive shape in TERRA called a G-quadruplex -- a folded structure -- and then recruits a natural enzyme in the cell, RNase L, to break down the RNA.\n\nThis marks the first demonstration of a tool that can destroy TERRA with such accuracy. The molecule selectively targets TERRA and does not affect other RNA molecules that share similar features.\n\nIn experiments using cancer cell lines such as HeLa and U2OS cells (which represent a hard-to-treat type of cancer), the treatment lowered TERRA levels and slowed cancer cell growth.\n\nPotential to Reshape Future Cancer Therapies\n\nThe finding points to the possibility of developing medicines that target RNA molecules directly -- not only proteins, which are the primary focus of most current drugs.\n\n\"This is a new way of thinking about medicine,\" said Benhamou. \"Instead of focusing only on proteins, we're now learning how to target the RNA that controls them. That could open the door to treating diseases we once thought were impossible to reach.\"",
      "url": "https://www.sciencedaily.com/releases/2025/11/251112111033.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2025-11-13",
      "sentiment_score": 0.9,
      "reasoning": "The article describes a significant scientific breakthrough in cancer treatment, where researchers developed a novel drug molecule that selectively destroys a specific RNA crucial for cancer cell survival. This approach offers a new, targeted method to slow cancer growth, potentially leading to innovative therapies with broad impact on cancer patients worldwide. The detailed explanation of the mechanism and experimental success provides substantial context and substance.",
      "category": "Health",
      "personality_title": "New drug targets hidden RNA to slow cancer growth",
      "personality_presentation": "**Context** – Cancer cells often rely on special molecules inside them to keep growing. One of these molecules is called TERRA, a type of RNA that helps protect the ends of chromosomes but can also help cancer cells survive.\n\n**What happened** – Scientists at the Hebrew University of Jerusalem created a new drug using a method called RIBOTAC. This drug acts like a guided missile to find and destroy TERRA RNA inside cancer cells without harming healthy parts. Tests on cancer cells showed that when TERRA is removed, cancer growth slows down.\n\n**Impact** – This drug is important because it targets RNA directly, not just proteins like most cancer treatments do. By focusing on the RNA that cancer cells depend on, the drug offers a new way to fight cancer at its core. It shows promise especially for tough cancers that are hard to treat.\n\n**What's next step** – Researchers will likely continue testing the drug in more types of cancer cells and eventually in animals and humans. If successful, this could lead to new medicines that attack cancer by destroying key RNA molecules.\n\n**One-sentence takeaway** – A new drug that destroys a special RNA in cancer cells could slow tumor growth and open new paths for cancer treatment.",
      "personality_title_fr": "Un nouveau médicament cible un ARN caché pour ralentir la croissance du cancer",
      "personality_presentation_fr": "**Contexte** – Les cellules cancéreuses dépendent souvent de molécules spéciales à l’intérieur d’elles pour continuer à grandir. L’une de ces molécules est appelée TERRA, un type d’ARN qui protège les extrémités des chromosomes mais peut aussi aider les cellules cancéreuses à survivre.\n\n**Ce qui s’est passé** – Des scientifiques de l’Université hébraïque de Jérusalem ont créé un nouveau médicament utilisant une méthode appelée RIBOTAC. Ce médicament agit comme un missile guidé pour trouver et détruire l’ARN TERRA à l’intérieur des cellules cancéreuses sans nuire aux parties saines. Les tests sur des cellules cancéreuses ont montré qu’en enlevant TERRA, la croissance du cancer ralentit.\n\n**Impact** – Ce médicament est important car il cible directement l’ARN, pas seulement les protéines comme la plupart des traitements contre le cancer. En se concentrant sur l’ARN dont les cellules cancéreuses ont besoin, il offre une nouvelle façon de combattre le cancer à sa source. Il montre un grand potentiel, surtout pour les cancers difficiles à traiter.\n\n**Prochaine étape** – Les chercheurs vont probablement continuer à tester ce médicament sur d’autres types de cellules cancéreuses puis chez les animaux et les humains. S’il fonctionne, cela pourrait mener à de nouveaux traitements qui détruisent des ARN clés du cancer.\n\n**Résumé en une phrase** – Un nouveau médicament qui détruit un ARN spécial dans les cellules cancéreuses pourrait ralentir la croissance des tumeurs et ouvrir de nouvelles voies pour traiter le cancer.",
      "personality_title_es": "Nuevo medicamento apunta a un ARN oculto para frenar el crecimiento del cáncer",
      "personality_presentation_es": "**Contexto** – Las células cancerosas a menudo dependen de moléculas especiales dentro de ellas para seguir creciendo. Una de estas moléculas se llama TERRA, un tipo de ARN que protege los extremos de los cromosomas pero que también ayuda a las células cancerosas a sobrevivir.\n\n**Qué pasó** – Científicos de la Universidad Hebrea de Jerusalén crearon un nuevo medicamento usando un método llamado RIBOTAC. Este medicamento actúa como un misil guiado para encontrar y destruir el ARN TERRA dentro de las células cancerosas sin dañar las partes sanas. Las pruebas en células cancerosas mostraron que al eliminar TERRA, el crecimiento del cáncer se ralentiza.\n\n**Impacto** – Este medicamento es importante porque apunta directamente al ARN, no solo a las proteínas como la mayoría de los tratamientos actuales contra el cáncer. Al enfocarse en el ARN que las células cancerosas necesitan, ofrece una nueva forma de atacar el cáncer desde su base. Muestra potencial especialmente para cánceres difíciles de tratar.\n\n**Próximo paso** – Los investigadores probablemente continuarán probando el medicamento en más tipos de células cancerosas y luego en animales y humanos. Si tiene éxito, podría llevar al desarrollo de nuevos medicamentos que destruyan ARN clave en el cáncer.\n\n**Resumen en una frase** – Un nuevo medicamento que destruye un ARN especial en células cancerosas podría frenar el crecimiento tumoral y abrir nuevas vías para tratar el cáncer.",
      "image_url": "public/images/news_image_Smart-drug-strikes-a-hidden-RNA-weak-point-in-canc.png",
      "image_prompt": "A detailed, warm painting of a glowing, intricately folded RNA strand shaped like a G-quadruplex at the center, with a small, elegant molecular “guided missile” gently approaching and breaking apart the RNA, all set against a soft, abstract cellular background in natural, muted tones."
    },
    {
      "title": "Physiology and immunology of pig-to-human decedent kidney xenotransplant",
      "summary": "Nature, Published online: 13 November 2025; doi:10.1038/s41586-025-09847-6Physiology and immunology of pig-to-human decedent kidney xenotransplant",
      "content": "Xenotransplantation of genetically-modified pig kidneys offers a solution to the scarcity of organs for end-stage renal disease patients.1 We performed a 61-day alpha-Gal knock-out pig kidney and thymic autograft transplant into a nephrectomized brain-dead human using clinically approved immunosuppression, without CD40 blockade or additional genetic modification. Hemodynamic and electrolyte stability and dialysis independence were achieved. Post-operative day (POD) 10 biopsies revealed glomerular IgM and IgA deposition, activation of early complement components and mesangiolysis with stable renal function without proteinuria, a phenotype not seen in allotransplantation. On POD 33, an abrupt increase in serum creatinine was associated with antibody-mediated rejection and increased donor-specific IgG. Plasma exchange, C3/C3b inhibition and rabbit anti-thymocyte globulin (rATG), completely reversed xenograft rejection. Pre-existing donor-reactive T cell clones expanded progressively in the circulation post-transplant, acquired an effector transcriptional profile and were detected in the POD 33 rejecting xenograft prior to rATG treatment. This study provides the first long-term physiologic, immunologic, and infectious disease monitoring of a pig-to-human kidney xenotransplant and indicates that pre-existing xenoreactive T cells and induced antibodies to unknown epitope(s) present a major challenge, despite significant immunosuppression. It also demonstrates that a minimally gene-edited pig kidney can support long-term life-sustaining physiologic functions in a human.",
      "url": "https://www.nature.com/articles/s41586-025-09847-6",
      "source": "Nature",
      "published": "2025-11-14",
      "sentiment_score": 0.9,
      "reasoning": "This article reports a significant medical breakthrough in xenotransplantation, demonstrating that a genetically-modified pig kidney can sustain life-supporting functions in a human for an extended period. This addresses the critical issue of organ scarcity for patients with end-stage renal disease, with broad implications for healthcare and transplantation medicine. The study includes detailed physiological and immunological findings, showing both challenges and successful management of rejection, indicating substantial progress in this field.",
      "category": "Health",
      "personality_title": "Genetically modified pig kidney supports human body for two months in groundbreaking transplant",
      "personality_presentation": "**Context** – Many people who need new kidneys cannot get them because there are not enough human donors. Scientists have been working on using pig kidneys that are specially changed to help solve this problem.\n\n**What happened** – In a recent experiment, doctors transplanted a kidney from a genetically modified pig into a brain-dead human who had no kidneys. This happened over 61 days, and the pig kidney was able to work properly, balancing fluids and chemicals in the body without needing dialysis. The patient was given medicines to stop the body from attacking the new kidney.\n\n**Impact** – This is the first time a pig kidney has worked for so long in a human body while keeping the body stable. The study showed that the body’s immune system did try to attack the kidney, but doctors were able to treat this successfully. It proves that pig kidneys, with just a few genetic changes, can support life functions in humans, which might help many patients waiting for transplants.\n\n**What's next step** – Researchers will continue to study how to stop the immune system from rejecting pig organs and improve treatments. This could lead to more trials in living patients and, eventually, new options for people needing kidney transplants.\n\n**One-sentence takeaway** – A genetically modified pig kidney kept a human body stable for two months, marking a major step toward solving the shortage of transplant organs.",
      "personality_title_fr": "Un rein de porc génétiquement modifié soutient un corps humain pendant deux mois dans une greffe révolutionnaire",
      "personality_presentation_fr": "**Contexte** – De nombreuses personnes ont besoin d’un nouveau rein, mais il n’y en a pas assez chez les donneurs humains. Les scientifiques travaillent à utiliser des reins de porc spécialement modifiés pour résoudre ce problème.\n\n**Ce qui s’est passé** – Dans une expérience récente, des médecins ont transplanté un rein provenant d’un porc génétiquement modifié dans un humain en état de mort cérébrale qui n’avait plus de reins. Cela a duré 61 jours, et le rein de porc a fonctionné correctement, en équilibrant les liquides et les substances chimiques dans le corps sans avoir besoin de dialyse. Le patient a reçu des médicaments pour empêcher le corps de rejeter le nouveau rein.\n\n**Impact** – C’est la première fois qu’un rein de porc fonctionne aussi longtemps dans un corps humain tout en maintenant la stabilité. L’étude a montré que le système immunitaire a essayé d’attaquer le rein, mais les médecins ont pu traiter cela avec succès. Cela prouve que les reins de porc, avec quelques modifications génétiques, peuvent soutenir les fonctions vitales chez l’humain, ce qui pourrait aider beaucoup de patients en attente de greffes.\n\n**Prochaine étape** – Les chercheurs vont continuer à étudier comment empêcher le système immunitaire de rejeter les organes de porc et améliorer les traitements. Cela pourrait conduire à plus d’essais chez des patients vivants et, à terme, offrir de nouvelles options pour les personnes ayant besoin de greffes de rein.\n\n**Résumé en une phrase** – Un rein de porc génétiquement modifié a maintenu un corps humain stable pendant deux mois, marquant une avancée majeure pour résoudre la pénurie d’organes de transplantation.",
      "personality_title_es": "Riñón de cerdo modificado genéticamente mantiene un cuerpo humano durante dos meses en un trasplante innovador",
      "personality_presentation_es": "**Contexto** – Muchas personas que necesitan un nuevo riñón no pueden obtenerlo porque no hay suficientes donantes humanos. Los científicos trabajan en usar riñones de cerdo modificados especialmente para ayudar a resolver este problema.\n\n**Qué pasó** – En un experimento reciente, médicos trasplantaron un riñón de un cerdo modificado genéticamente a un humano con muerte cerebral que no tenía riñones. Esto duró 61 días, y el riñón de cerdo funcionó bien, equilibrando líquidos y químicos en el cuerpo sin necesidad de diálisis. El paciente recibió medicamentos para evitar que el cuerpo rechazara el nuevo riñón.\n\n**Impacto** – Es la primera vez que un riñón de cerdo funciona tanto tiempo en un cuerpo humano manteniendo la estabilidad. El estudio mostró que el sistema inmunológico intentó atacar el riñón, pero los médicos lograron tratar ese rechazo con éxito. Esto demuestra que riñones de cerdo con pocos cambios genéticos pueden apoyar funciones vitales en humanos, lo que podría ayudar a muchos pacientes que esperan un trasplante.\n\n**Próximo paso** – Los investigadores seguirán estudiando cómo evitar que el sistema inmunológico rechace los órganos de cerdo y mejorarán los tratamientos. Esto podría llevar a más pruebas en pacientes vivos y, eventualmente, a nuevas opciones para quienes necesitan trasplantes de riñón.\n\n**Frase clave** – Un riñón de cerdo modificado genéticamente mantuvo estable un cuerpo humano durante dos meses, marcando un gran avance para solucionar la escasez de órganos para trasplantes.",
      "image_url": "public/images/news_image_Physiology-and-immunology-of-pig-to-human-decedent.png",
      "image_prompt": "A detailed, warm painting of a sturdy, anatomically stylized pig kidney gently cradled within a human-shaped silhouette made of soft, glowing light, surrounded by delicate, translucent cellular patterns symbolizing immune cells and antibodies harmoniously interacting, all rendered in natural, muted earth tones and soft pastels."
    },
    {
      "title": "Tiny robots swim through blood, deliver drugs — and then dissolve",
      "summary": "Nature, Published online: 13 November 2025; doi:10.1038/d41586-025-03754-6A tiny bead filled with a drug is guided by magnets to parts of the body, a trial in animals has shown.",
      "content": "The tiny, drug-filled robots are guided through blood vessels using magnets.Credit: Luca Donati/lad.studio Zürich\n\nA remote-controlled robot the size of a grain of sand can swim through blood vessels to deliver drugs before dissolving into the body. The technology could allow doctors to administer small amounts of drugs to specific sites, avoiding the toxic side effects of body-wide therapies.\n\nThe microrobots — guided by magnetic fields — work in blood vessels in pigs and sheep, researchers showed in a paper published in Science on 13 November1.\n\nThe system has yet to be trialled in people, but it shows promise because it works in a roughly human-sized body, and because all its components have already been shown to be biocompatible, says Bradley Nelson, a mechanical engineer at Swiss Federal Institute of Technology (ETH) in Zurich, who co-led the work.\n\nAround one-third of developed drugs that fail to come to market do so because they’re too toxic2, says Nelson. The team says the microrobots would allow smaller amounts of drugs to be given directly to the affected areas, thereby reducing potential side effects. The technique could be used to target stroke-causing blockages or brain tumours.\n\n“The demonstrations are compelling but still preclinical,” says Wei Gao, a medical engineer at the California Institute of Technology in Pasadena, whose team has developed an alternative robotic drug-delivery system. But if further studies proceed smoothly, remote-controlled drug-delivery robots could be used in the first medical applications within five to ten years, he says.\n\nCredit: ETH Zürich\n\nRobot-delivered drugs\n\nResearchers have explored how to use tiny robots to deliver drugs for decades, including by steering them using ultrasound and using rotating devices that mimic bacteria.\n\nThe system developed by the ETH team involves filling a tiny bead of gelatine with a drug, as well as nanoparticles of magnetic iron oxide, which allows its movement to be controlled by magnetic fields surrounding the patient.\n\nIn trials in the brains of pigs and sheep, the team showed that they could use a catheter to insert the bots, before making them roll along the edges of blood vessels, swim against the flow or navigate with the stream at speeds as fast as 40 centimetres per second. They used X-ray images to observe and manoeuvre the bots in real time with millimetre-precision. In trials in pigs, the team showed that in more than 95% of cases, the drugs were delivered to the correct location.",
      "url": "https://www.nature.com/articles/d41586-025-03754-6",
      "source": "Nature",
      "published": "2025-11-14",
      "sentiment_score": 0.9,
      "reasoning": "The article reports a significant medical breakthrough where tiny, magnetically guided robots can deliver drugs precisely within blood vessels, reducing toxic side effects and improving treatment efficacy. The technology has been successfully trialed in large animals with promising results, indicating broad potential benefits for human health, especially in targeting conditions like strokes and brain tumors. The detailed description of the technology and its impact meets the criteria for inspiring, substantive good news with meaningful real-world benefits.",
      "category": "Health",
      "personality_title": "Tiny robots swim through blood to deliver medicine and then dissolve",
      "personality_presentation": "**Context** – Scientists have been trying for years to use tiny robots to deliver medicine directly inside the body. This method could help give drugs exactly where they are needed, without causing side effects in other parts of the body.\n\n**What happened** – Researchers at the Swiss Federal Institute of Technology (ETH) in Zurich created tiny robots the size of a grain of sand. These robots are filled with medicine and tiny magnetic particles. Using magnets outside the body, doctors can guide the robots through blood vessels in pigs and sheep to deliver drugs to specific places. After delivering the medicine, the robots dissolve safely inside the body.\n\n**Impact** – This is important because many medicines can cause harmful side effects when they spread throughout the whole body. By sending tiny robots to deliver drugs directly to problem areas, like blocked blood vessels or brain tumors, treatments can be safer and more effective. In tests, the robots reached the right spot over 95% of the time, showing they can be very precise.\n\n**What's next step** – The technology still needs to be tested in people. If those tests go well, these tiny robots could be used in hospitals within five to ten years. Scientists will continue improving the robots and making sure they work safely in humans.\n\n**One-sentence takeaway** – Tiny magnetic robots have been successfully tested in animals to deliver medicine precisely inside blood vessels, offering a new way to treat diseases with fewer side effects.",
      "personality_title_fr": "De minuscules robots nagent dans le sang pour délivrer des médicaments puis se dissolvent",
      "personality_presentation_fr": "**Contexte** – Les scientifiques essaient depuis des années d'utiliser de minuscules robots pour administrer des médicaments directement à l'intérieur du corps. Cette méthode pourrait aider à envoyer les médicaments exactement là où ils sont nécessaires, sans provoquer d'effets secondaires ailleurs.\n\n**Ce qui s'est passé** – Des chercheurs de l'École polytechnique fédérale de Zurich (ETH) ont créé de minuscules robots de la taille d'un grain de sable. Ces robots sont remplis de médicaments et de petites particules magnétiques. Grâce à des aimants placés à l'extérieur du corps, les médecins peuvent guider les robots dans les vaisseaux sanguins de cochons et de moutons pour délivrer les médicaments à des endroits précis. Après avoir libéré le médicament, les robots se dissolvent en toute sécurité dans le corps.\n\n**Impact** – C’est important car beaucoup de médicaments peuvent provoquer des effets secondaires nocifs quand ils se répandent dans tout le corps. En envoyant de petits robots pour délivrer les médicaments directement là où il y a un problème, comme des vaisseaux bloqués ou des tumeurs au cerveau, les traitements peuvent être plus sûrs et plus efficaces. Dans les tests, les robots ont atteint la bonne cible plus de 95 % du temps, montrant qu’ils sont très précis.\n\n**Prochaine étape** – La technologie doit encore être testée chez l'humain. Si ces essais réussissent, ces petits robots pourraient être utilisés à l’hôpital dans cinq à dix ans. Les scientifiques vont continuer à améliorer les robots et à vérifier qu’ils fonctionnent en toute sécurité chez les humains.\n\n**Conclusion en une phrase** – De minuscules robots magnétiques ont été testés avec succès sur des animaux pour délivrer des médicaments précisément dans les vaisseaux sanguins, ouvrant une nouvelle voie pour traiter les maladies avec moins d'effets secondaires.",
      "personality_title_es": "Pequeños robots nadan por la sangre para entregar medicinas y luego se disuelven",
      "personality_presentation_es": "**Contexto** – Los científicos han intentado durante años usar pequeños robots para administrar medicinas directamente dentro del cuerpo. Esta forma podría ayudar a llevar las medicinas justo donde se necesitan, sin causar efectos secundarios en otras partes.\n\n**Qué pasó** – Investigadores del Instituto Federal Suizo de Tecnología (ETH) en Zúrich crearon robots diminutos del tamaño de un grano de arena. Estos robots están llenos de medicina y pequeñas partículas magnéticas. Usando imanes fuera del cuerpo, los médicos pueden guiar los robots a través de los vasos sanguíneos de cerdos y ovejas para entregar medicinas en lugares específicos. Después de entregar la medicina, los robots se disuelven de manera segura dentro del cuerpo.\n\n**Impacto** – Esto es importante porque muchas medicinas pueden causar efectos secundarios dañinos cuando se esparcen por todo el cuerpo. Al enviar robots pequeños para entregar medicinas directamente en las áreas problemáticas, como vasos bloqueados o tumores cerebrales, los tratamientos pueden ser más seguros y efectivos. En las pruebas, los robots llegaron al lugar correcto más del 95% de las veces, mostrando que son muy precisos.\n\n**Próximo paso** – La tecnología aún debe probarse en humanos. Si esas pruebas salen bien, estos pequeños robots podrían usarse en hospitales dentro de cinco a diez años. Los científicos seguirán mejorando los robots y asegurándose de que funcionen con seguridad en personas.\n\n**Conclusión en una frase** – Robots magnéticos diminutos han sido probados con éxito en animales para entregar medicina con precisión dentro de los vasos sanguíneos, ofreciendo una nueva forma de tratar enfermedades con menos efectos secundarios.",
      "image_url": "public/images/news_image_Tiny-robots-swim-through-blood-deliver-drugs-and-t.png",
      "image_prompt": "A detailed, warm-toned painting of tiny, glowing, translucent beads embedded with small magnetic particles gracefully swimming and rolling along the inner walls of a stylized, gently curving blood vessel, guided by soft, swirling magnetic waves depicted as delicate, flowing lines, with subtle hints of medicine droplets releasing from the beads, all rendered in natural, muted reds, pinks, and soft metallic hues."
    },
    {
      "title": "Protecting lives in a warming world: Health takes centre stage at COP30",
      "summary": "Hailed by Brazil as “a crucial moment to demonstrate the strength of the health sector in global climate action,” a blueprint for global health systems to adapt to rising temperatures and extreme weather has been launched at the COP30 UN climate conference.",
      "content": "As climate negotiations continue in the Amazonian city of Belém, Brazil, governments, UN agencies and partners have adopted the Belém Health Action Plan, placing an emphasis on addressing healthcare inequalities.\n\nFor updates on all the action and UN News coverage so far, head to our dedicated page here.\n\nA planet heading to ‘intensive care’\n\nThe adoption took place on COP’s designated Health Day – a recognition that the climate crisis is also a health crisis.\n\n“If our planet were a patient, it would be admitted to intensive care,” World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus warned on the eve of the conference.\n\nExtreme heat, floods, droughts and storms are not only environmental threats –they are driving disease outbreaks, food and water insecurity, and the disruption of essential health services.\n\n© UNFPA A UNFPA mobile health clinic midwife assesses a pregnant woman at a displacement camp in Marib, Yemen.\n\nBlueprint for resilience\n\nDeveloped by the WHO, UN University (UNU) and other UN partners in collaboration with the Brazilian Government, the Action Plan sets out practical steps to integrate health into climate strategies\n\nStrengthening health systems to withstand climate shocks\n\nto withstand climate shocks Mobilising finance and technology for adaptation and\n\nfor adaptation and Ensuring communities have a voice, promoting their participation in governance.\n\nBrazil’s Health Minister Alexandre Padilha described the launch as “a crucial moment to demonstrate the strength of the health sector in global climate action”\n\n© UNFCCC/Diego Herculano Civil society demonstration at COP30\n\nSolutions hub\n\nThursday’s high-level sessions in the main conference rooms are dominated by speeches and discussions about climate and health – but throughout COP30, the WHO-led Health Pavilion has been the hub for solutions and dialogue.\n\nThe topics covered at the pavilion range from AI to waste management, jobs, education and human rights – all from the perspective of health.\n\nFriday in the pavilion will be dedicated to the Alliance for Transformative Action on Climate and Health, a WHO-led initiative to accelerate the transition to climate-resilient and low carbon health systems.\n\nFood Waste Breakthrough\n\nAlso today, the UN Environment Programme (UNEP) and its partners launched an initiative to cut food waste in half by 2030 and cut up to seven per cent of methane emissions as part of efforts to slow climate change.\n\nUNEP notes that the world wastes more than one billion tonnes of food every year, contributing up to 10 per cent of global greenhouse gas emissions and accounting for up to 14 per cent of methane emissions, which is a short-lived climate pollutant that is 84 times more potent at warming the atmosphere than carbon dioxide over 20 years.\n\nFunded by the Global Environment Facility, the UN Environment Programme will launch a $3 million, four-year global project to implement the targets of the Food Waste Breakthrough.",
      "url": "https://news.un.org/feed/view/en/story/2025/11/1166357",
      "source": "UN News - Global perspective Human stories",
      "published": "2025-11-13",
      "sentiment_score": 0.9,
      "reasoning": "The article reports on the adoption of the Belém Health Action Plan at COP30, a significant global initiative integrating health systems adaptation into climate strategies. This plan addresses healthcare inequalities and strengthens resilience against climate-related health threats, representing a meaningful, large-scale benefit for global public health. The article provides detailed context on the plan's development, goals, and related initiatives, demonstrating substantial positive real-world impact.",
      "category": "Health",
      "personality_title": "Global health systems unite to face climate challenges at COP30",
      "personality_presentation": "**Context** – At COP30, the United Nations climate conference held in Belém, Brazil, leaders and organizations gathered to address how climate change affects health. Rising temperatures and extreme weather events are making people sick and damaging health services worldwide.\n\n**What happened** – The Belém Health Action Plan was launched during the conference’s Health Day. This plan was created by the World Health Organization (WHO), the United Nations University, Brazil, and other partners. It aims to help health systems around the world prepare for and respond to climate risks. The plan focuses on reducing health inequalities, improving services during climate disasters, and involving communities in decision-making.\n\n**Impact** – This action plan is important because it links health directly to climate change, recognizing that protecting people’s health is a key part of fighting the climate crisis. It also encourages using new technology and funding to make health systems stronger. For example, it supports efforts to keep hospitals running during floods or heatwaves and ensures that all communities, especially vulnerable ones, have a say in how health and climate policies are made.\n\n**What's next step** – Over the coming years, the WHO and its partners will work to put the Belém Health Action Plan into practice worldwide. At COP30, the WHO-led Health Pavilion will continue to share ideas and support projects, including the Alliance for Transformative Action on Climate and Health, which helps health systems become more climate-friendly. Additionally, the UN Environment Programme launched a food waste reduction initiative, aiming to cut food waste by half by 2030 to reduce greenhouse gases.\n\n**One-sentence takeaway** – The Belém Health Action Plan at COP30 marks a global effort to protect health by making healthcare systems stronger and more prepared for the effects of climate change.",
      "personality_title_fr": "Les systèmes de santé mondiaux unis pour relever les défis climatiques à la COP30",
      "personality_presentation_fr": "**Contexte** – Lors de la COP30, la conférence climatique des Nations Unies à Belém, au Brésil, des dirigeants et organisations se sont réunis pour discuter de l’impact du changement climatique sur la santé. La hausse des températures et les phénomènes météorologiques extrêmes rendent les gens malades et perturbent les services de santé dans le monde.\n\n**Ce qui s'est passé** – Le Plan d’action pour la santé de Belém a été lancé lors de la Journée de la santé de la conférence. Ce plan a été créé par l’Organisation mondiale de la santé (OMS), l’Université des Nations Unies, le Brésil et d’autres partenaires. Il vise à aider les systèmes de santé à se préparer et à répondre aux risques liés au climat. Le plan met l’accent sur la réduction des inégalités en santé, l’amélioration des services lors des catastrophes climatiques et la participation des communautés aux décisions.\n\n**Impact** – Ce plan est important car il relie directement la santé au changement climatique, reconnaissant que protéger la santé est une partie essentielle de la lutte contre la crise climatique. Il encourage aussi l’utilisation de nouvelles technologies et financements pour renforcer les systèmes de santé. Par exemple, il soutient les efforts pour maintenir les hôpitaux ouverts lors d’inondations ou de vagues de chaleur et garantit que toutes les communautés, surtout les plus vulnérables, puissent s’exprimer sur les politiques de santé et climat.\n\n**Prochaine étape** – Dans les années à venir, l’OMS et ses partenaires travailleront à la mise en œuvre du Plan d’action pour la santé de Belém dans le monde. Lors de la COP30, le Pavillon Santé dirigé par l’OMS continuera de partager des idées et de soutenir des projets, comme l’Alliance pour une action transformatrice sur le climat et la santé, qui aide les systèmes de santé à devenir plus respectueux du climat. De plus, le Programme des Nations Unies pour l’environnement a lancé une initiative pour réduire de moitié le gaspillage alimentaire d’ici 2030 afin de diminuer les gaz à effet de serre.\n\n**Conclusion en une phrase** – Le Plan d’action pour la santé de Belém à la COP30 marque un effort mondial pour protéger la santé en rendant les systèmes de santé plus solides et mieux préparés aux effets du changement climatique.",
      "personality_title_es": "Sistemas de salud globales se unen para enfrentar desafíos climáticos en la COP30",
      "personality_presentation_es": "**Contexto** – En la COP30, la conferencia climática de las Naciones Unidas en Belém, Brasil, líderes y organizaciones se reunieron para abordar cómo el cambio climático afecta la salud. El aumento de temperaturas y eventos climáticos extremos están enfermando a las personas y dañando los servicios de salud en todo el mundo.\n\n**Qué pasó** – Durante el Día de la Salud de la conferencia, se lanzó el Plan de Acción de Salud de Belém. Este plan fue creado por la Organización Mundial de la Salud (OMS), la Universidad de las Naciones Unidas, Brasil y otros socios. Su objetivo es ayudar a los sistemas de salud a prepararse y responder a los riesgos climáticos. El plan se centra en reducir las desigualdades en salud, mejorar los servicios durante desastres climáticos y asegurar la participación de las comunidades en la toma de decisiones.\n\n**Impacto** – Este plan es importante porque conecta la salud directamente con el cambio climático, reconociendo que proteger la salud es una parte clave para enfrentar la crisis climática. También promueve el uso de nuevas tecnologías y financiamiento para fortalecer los sistemas de salud. Por ejemplo, apoya mantener hospitales en funcionamiento durante inundaciones o olas de calor y asegura que todas las comunidades, especialmente las vulnerables, tengan voz en las políticas de salud y clima.\n\n**Próximo paso** – En los próximos años, la OMS y sus socios trabajarán para implementar el Plan de Acción de Salud de Belém en todo el mundo. En la COP30, el Pabellón de Salud liderado por la OMS seguirá compartiendo ideas y apoyando proyectos, incluida la Alianza para la Acción Transformadora sobre Clima y Salud, que ayuda a los sistemas de salud a ser más amigables con el clima. Además, el Programa de las Naciones Unidas para el Medio Ambiente lanzó una iniciativa para reducir a la mitad el desperdicio de alimentos para 2030 y así disminuir los gases de efecto invernadero.\n\n**Frase clave** – El Plan de Acción de Salud de Belém en la COP30 representa un esfuerzo global para proteger la salud fortaleciendo los sistemas de salud y preparándolos mejor para los efectos del cambio climático.",
      "image_url": "public/images/news_image_Protecting-lives-in-a-warming-world-Health-takes-c.png",
      "image_prompt": "A vibrant, detailed painting of a large, healthy human heart made of lush green leaves and vines, cradled gently by hands formed from flowing river water, set against a warm backdrop of the Amazon rainforest with subtle outlines of medical symbols like a stethoscope and a mobile clinic silhouette integrated into the foliage, symbolizing the fusion of health care and climate action in the Amazonian city of Belém."
    }
  ]
}